Bellerophon Therapeutics Inc (BLPH): Bellerophon Provides Clinical Program Up...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Bellerophon Therapeutics Inc (BLPH)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	37
Posts	7745
Boards Moderated	2
Alias Born	11/14/2019

Re: None

Saturday, 10/01/2022 7:35:49 PM

Saturday, October 01, 2022 7:35:49 PM

Bellerophon Provides Clinical Program Update and Reports Second Quarter 2022 Financial Results
08/15/2022 12:30 PM
WARREN, N.J. , Aug. 15, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent BLPH News

Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 02:29:00 PM
Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/26/2024 07:31:31 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/26/2024 03:46:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 08:21:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:05:20 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/03/2024 06:49:05 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/27/2023 02:50:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2023 12:51:41 AM
Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 10/16/2023 05:59:54 PM
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 10/16/2023 05:59:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 02:30:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 12:45:13 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:30:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:05:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 08:10:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/20/2023 08:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/14/2023 08:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 08:06:11 PM

More BLPH News

InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow